MACA
Moringa Acquisition Corp - Ordinary Shares - Class A

90
Loading...
Loading...
News
all
press releases
News Placeholder
Moringa Acquisition Corp to take Silexion public via merger
Moringa Acquisition Corp to take Silexion public via merger...
SeekingAlpha.com: All News·2y ago
News Placeholder
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Silexion's first generation product, Loder , successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors an oncogene believed to be...
Globe Newswire·2y ago

Latest MACA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.